| Financial Year |
March 31 2023 |
| Monetary Funds |
13,658,558,539.51 |
| Held-for-trading Financial Assets |
12,278,655.84 |
| Notes Receivable |
6,009,539.72 |
| Accounts Receivable |
831,347,090.81 |
| Advances to Suppliers |
3,095,856,127.86 |
| Other Receivables |
60,752,897.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,036,072,817.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
89,701,006.28 |
| Total Current Assets |
25,701,712,905.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,073,898,901.15 |
| Long-term Equity Investment |
5,198,493,817.61 |
| Investment Properties |
134,552,275.32 |
| Fixed Assetes |
5,293,826,622.82 |
| Under-construction Projects |
332,003,042.76 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
902,802,375.66 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
53,115,551.60 |
| Deferred Income Tax Assets |
353,960,746.39 |
| Other Non-Current Assets |
814,627,168.20 |
| Sub-Total of Non-Current Assets |
20,477,538,722.61 |
| Total Assets |
46,179,251,628.52 |
| Short-Term Loans |
2,546,463,183.34 |
| Trading Financial liabilities |
2,032,778.36 |
| Notes Payable |
2,535,412,988.99 |
| Accounts Payable |
5,383,030,068.10 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
83,624,435.63 |
| Taxes Payable |
18,474,806.71 |
| Interest Payable |
-- |
| Dividend Payable |
761,400.08 |
| Other payables |
268,619,224.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
956,334,736.35 |
| Other Current Liabilities |
117,267,490.65 |
| Sub-Total of Current Liabilities |
24,499,882,292.18 |
| Long-term Loans |
1,931,044,398.90 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
130,785,302.54 |
| Deferred Income Tax Liabilities |
561,749,594.80 |
| Other Non-Current Liabilities |
236,238,270.41 |
| Sub-Total of Non-Current Liabilities |
3,174,412,725.51 |
| Total Liabilities |
27,674,295,017.69 |
| Paid-In Capital(Or Share Stock) |
1,413,506,378.00 |
| Capital Surplus |
9,001,619,702.14 |
| Surplus Reserve |
1,111,646,419.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,209,675,753.61 |
| Minority Stockholder's Interest |
3,136,316,708.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,368,639,902.74 |
| Owner's Equity（Stockholder's Equity） |
18,504,956,610.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
46,179,251,628.52 |
